Continuous Glucose Monitors – Medical Devices Pipeline Product Landscape, 2021

Continuous glucose monitoring system is used for the continuous measurement of blood glucose. The system includes an implantable sensor with wireless transmission capability and a monitor. GlobalData's Medical Devices sector report, "Continuous Glucose Monitors – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Continuous Glucose Monitors Pipeline Landscape report provides key information and data related to:

Extensive coverage of the Continuous Glucose Monitors under development

Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates

Reviews of major players involved in the pipeline product development.

Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Continuous Glucose Monitors pipeline products.

Review of Recent Developments in the segment / industry

The Continuous Glucose Monitors Pipeline Landscape report enables you to:

Access significant competitor information, analysis, and insights to improve your R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

Identify and understand important and diverse types of Glaucoma Drainage Device sunder development

Formulate market-entry and market expansion strategies

Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025

• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports

• 64,000+ medical equipment company profiles

• 5,600+ company profiles of medical equipment manufacturers in China and India

• 2,200+ company profiles of medical equipment manufacturers in Japan

• 1,200+ companies’ revenue splits and market shares

• 1,600+ quarterly and annual medical equipment company financials

• 850+ medical equipment company SWOTs

• 28,000+ pipeline product profiles

• 56,400+ marketed product profiles

• 47,000+ clinical trials

• 41,500+ trial investigators

• 7,000+ reports on companies with products in development

• 44,000+ deals in the medical equipment industry

• 1,100+ surgical and diagnostic procedures by therapy area

• 50+ key healthcare indicators by country

• 431,000+ Themes Content Items

• 600+ Influencers

• 1,900+ Analysts & Researchers

• 0.5m+ Community Members

• 141,000+ Macroeconomic Indicators

• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:

https://medical.globaldata.com/home.aspx

Custom Requirements

Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Continuous Glucose Monitors under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Continuous Glucose Monitors under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Companies mentioned

Abbott Diabetes Care Inc

Advanced Biosensors-Ohio LLC

Advanced Medical Electronics Corp

Arkal Medical Inc (Inactive)

Azurite Technologies, Inc. (Inactive)

Biovotion AG

CALISTO MEDICAL, INC. (Inactive)

CGM3 Ltd

City, University of London

Columbia University

ConvaTec Group Plc

Cyber Medical Ltd

DexCom Inc

DexCom Inc

Echo Therapeutics Inc

Echo Therapeutics Inc

Echo Therapeutics Inc

Ecole Polytechnique Federale de Lausanne

eLutions Integrated Systems, Inc.

EyeSense GmbH

Flowsion A/S

Gili Medical Ltd

Globe Medical Tech Inc (Inactive)

GlucoLight Corporation (Inactive)

Glucometrix AG

Glucosense Diagnostics Ltd (Inactive)

GlucoSet AS

GluMetrics Inc

Glusense Ltd

GlySens Inc

GlySens Inc

G-Sense Ltd.

iGlyko, Inc. (Inactive)

Indigo Diabetes NV

Innovosens AB

Insulet Corp

Integrated Medical Sensors

Integrity Applications Ltd

Integrity Applications Ltd

Integrity Applications Ltd

Invivosense ASA (Inactive)

I-Sens Inc

iSense Corporation (Inactive)

Keratin Biosciences Inc

Know Labs Inc

KTH Royal Institute of Technology

LEMM Technologies, LLC

Massachusetts Institute of Technology

Medical Wireless Sensing Ltd

Medtronic Diabetes

Medtronic Diabetes

Medtronic Diabetes

Medtronic Diabetes

Medtronic Diabetes

Medtronic Diabetes

Medtronic Diabetes

Mellitor Ltd

Metronom Health Inc

mobiLIFE

Nemaura Medical Inc

Newton Photonics Inc

Northwestern University

Orsus Medical Ltd

PKvitality SAS

PositiveID Corp

Purdue University

Senseonics Holdings Inc

SensiVida Medical Technologies, Inc. (Inactive)

Senzime AB

Socrates Health Solutions, Inc.

Stony Brook University

Swansea University

Swansea University

Tenax Therapeutics Inc

Texas A&M University

Ultradian Diagnostics LLC

University of California Berkeley

University of California Irvine

University of California San Diego

University of South Carolina

University of South Florida

University of Technology Sydney

University of Texas at Arlington

VeriTeQ Corporation

Vytrace, Inc.

WaveForm Technologies Inc

Zyvex Corp

Table of Contents

1 Table of Contents

2 Introduction 13

2.1 Continuous Glucose Monitors Overview 13

3 Products under Development 14

3.1 Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

3.2 Continuous Glucose Monitors – Pipeline Products by Territory 15

3.3 Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

3.4 Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

3.5 Continuous Glucose Monitors – Ongoing Clinical Trials 18

4 Continuous Glucose Monitors – Pipeline Products under Development by Companies 19

4.1 Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 19

4.2 Continuous Glucose Monitors – Pipeline Products by Stage of Development 22

5 Continuous Glucose Monitors Companies and Product Overview 25

5.1 Abbott Diabetes Care Inc Company Overview 25

5.1.1 Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25

5.2 Advanced Biosensors-Ohio LLC Company Overview 28

5.2.1 Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 28

5.3 Advanced Medical Electronics Corp Company Overview 29

5.3.1 Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 29

5.4 Arkal Medical Inc (Inactive) Company Overview 30

5.4.1 Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

5.5 Azurite Technologies, Inc. (Inactive) Company Overview 31

5.5.1 Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31

5.6 Biovotion AG Company Overview 32

5.6.1 Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 32

5.7 CALISTO MEDICAL, INC. (Inactive) Company Overview 33

5.7.1 CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

5.8 CGM3 Ltd Company Overview 34

5.8.1 CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

5.9 City, University of London Company Overview 35

5.9.1 City, University of London Pipeline Products & Ongoing Clinical Trials Overview 35

5.10 Columbia University Company Overview 36

5.10.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 36

5.11 ConvaTec Group Plc Company Overview 37

5.11.1 ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 37

5.12 Cyber Medical Ltd Company Overview 38

5.12.1 Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

5.13 DexCom Inc Company Overview 39

5.13.1 DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 39

5.14 Echo Therapeutics Inc Company Overview 41

5.14.1 Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41

5.15 Ecole Polytechnique Federale de Lausanne Company Overview 44

5.15.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 44

5.16 eLutions Integrated Systems, Inc. Company Overview 45

5.16.1 eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

5.17 EyeSense GmbH Company Overview 46

5.17.1 EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 46

5.18 Flowsion A/S Company Overview 49

5.18.1 Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 49

5.19 Gili Medical Ltd Company Overview 50

5.19.1 Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

5.20 Globe Medical Tech Inc (Inactive) Company Overview 51

5.20.1 Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

5.21 GlucoLight Corporation (Inactive) Company Overview 52

5.21.1 GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52

5.22 Glucometrix AG Company Overview 53

5.22.1 Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 53

5.23 Glucosense Diagnostics Ltd (Inactive) Company Overview 54

5.23.1 Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54

5.24 GlucoSet AS Company Overview 55

5.24.1 GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 55

5.25 GluMetrics Inc Company Overview 56

5.25.1 GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 56

5.26 Glusense Ltd Company Overview 57

5.26.1 Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

5.27 GlySens Inc Company Overview 60

5.27.1 GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 60

5.28 G-Sense Ltd. Company Overview 62

5.28.1 G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62

5.29 iGlyko, Inc. (Inactive) Company Overview 63

5.29.1 iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63

5.30 Indigo Diabetes NV Company Overview 64

5.30.1 Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 64

5.31 Innovosens AB Company Overview 67

5.31.1 Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 67

5.32 Insulet Corp Company Overview 68

5.32.1 Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 68

5.33 Integrated Medical Sensors Company Overview 69

5.33.1 Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 69

5.34 Integrity Applications Ltd Company Overview 70

5.34.1 Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

5.35 Invivosense ASA (Inactive) Company Overview 73

5.35.1 Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

5.36 I-Sens Inc Company Overview 74

5.36.1 I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 74

5.37 iSense Corporation (Inactive) Company Overview 75

5.37.1 iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75

5.38 Keratin Biosciences Inc Company Overview 76

5.38.1 Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 76

5.39 Know Labs Inc Company Overview 77

5.39.1 Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.40 KTH Royal Institute of Technology Company Overview 78

5.40.1 KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 78

5.41 LEMM Technologies, LLC Company Overview 79

5.41.1 LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 79

5.42 Massachusetts Institute of Technology Company Overview 80

5.42.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 80

5.43 Medical Wireless Sensing Ltd Company Overview 81

5.43.1 Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.44 Medtronic Diabetes Company Overview 82

5.44.1 Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview 82

5.45 Mellitor Ltd Company Overview 87

5.45.1 Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

5.46 Metronom Health Inc Company Overview 88

5.46.1 Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 88

5.47 mobiLIFE Company Overview 89

5.47.1 mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 89

5.48 Nemaura Medical Inc Company Overview 90

5.48.1 Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 90

5.49 Newton Photonics Inc Company Overview 94

5.49.1 Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 94

5.50 Northwestern University Company Overview 95

5.50.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 95

5.51 Orsus Medical Ltd Company Overview 96

5.51.1 Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

5.52 PKvitality SAS Company Overview 97

5.52.1 PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 97

5.53 PositiveID Corp Company Overview 98

5.53.1 PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 98

5.54 Purdue University Company Overview 99

5.54.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview 99

5.55 Senseonics Holdings Inc Company Overview 100

5.55.1 Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 100

5.56 SensiVida Medical Technologies, Inc. (Inactive) Company Overview 103

5.56.1 SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

5.57 Senzime AB Company Overview 104

5.57.1 Senzime AB Pipeline Products & Ongoing Clinical Trials Overview 104

5.58 Socrates Health Solutions, Inc. Company Overview 105

5.58.1 Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105

5.59 Stony Brook University Company Overview 106

5.59.1 Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 106

5.60 Swansea University Company Overview 107

5.60.1 Swansea University Pipeline Products & Ongoing Clinical Trials Overview 107

5.61 Tenax Therapeutics Inc Company Overview 109

5.61.1 Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 109

5.62 Texas A&M University Company Overview 110

5.62.1 Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 110

5.63 Ultradian Diagnostics LLC Company Overview 111

5.63.1 Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 111

5.64 University of California Berkeley Company Overview 112

5.64.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 112

5.65 University of California Irvine Company Overview 113

5.65.1 University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 113

5.66 University of California San Diego Company Overview 114

5.66.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 114

5.67 University of South Carolina Company Overview 115

5.67.1 University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 115

5.68 University of South Florida Company Overview 116

5.68.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 116

5.69 University of Technology Sydney Company Overview 117

5.69.1 University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 117

5.70 University of Texas at Arlington Company Overview 118

5.70.1 University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 118

5.71 VeriTeQ Corporation Company Overview 119

5.71.1 VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 119

5.72 Vytrace, Inc. Company Overview 120

5.72.1 Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview 120

5.73 WaveForm Technologies Inc Company Overview 121

5.73.1 WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.74 Zyvex Corp Company Overview 124

5.74.1 Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview 124

6 Continuous Glucose Monitors- Recent Developments 125

6.1 May 06, 2021: Insulet Reports First Quarter 2021 Revenue Increase of 27% Year-Over-Year 125

6.2 May 04, 2021: Henry Schein Reports Record First-Quarter 2021 Financial Results from Continuing Operations 126

6.3 Apr 21, 2021: Integrity Applications Announces the Appointment of David C. Klonoff, MD as Chair of Scientific Advisory Board 128

6.4 Apr 20, 2021: Henry Schein to Webcast First Quarter 2021 Conference Call on Tuesday, May 4, 2021 at 10:00 A.M. Eastern Time 128

6.5 Apr 05, 2021: Insulet to Announce First Quarter 2021 Financial Results on May 6, 2021 129

6.6 Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems 129

6.7 Mar 17, 2021: Ching Tang, Innovator in OLED Technology, to be Featured in Virtual Kyoto Prize Symposium by UC San Diego, March 25 130

6.8 Mar 10, 2021: Nemaura Medical to Present at Maxim Group’s Inaugural Emerging Growth Virtual Conference 130

6.9 Mar 04, 2021: Nemaura Medical Appoints Industry Veteran Alistair Longmuir as Advisor on Global Product Manufacture Strategy 130

6.10 Feb 23, 2021: Will Weatherford elected vice chair of the USF Board of Trustees 131

6.11 Feb 22, 2021: Henry Schein to Present at the 2021 Barclays Global Healthcare Conference 132

6.12 Feb 19, 2021: Engineer-turned-Artist Named Associate Director of Interdisciplinary Institute 132

6.13 Feb 17, 2021: Henry Schein Reports Fourth Quarter 2020 Financial Results From Continuing Operations 133

6.14 Feb 17, 2021: St. Petersburg Conference on World Affairs to provide global perspective and insight into historic turmoil 135

6.15 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021 136

6.16 Feb 16, 2021: Tandem Diabetes Care Announces Upcoming Virtual Conference Presentations 136

6.17 Feb 04, 2021: Nemaura Medical Appoints Thomas Mortensen as Head of E.U. Commercial Operations and Marketing 136

6.18 Feb 01, 2021: Nemaura Medical Appoints Jay L. Warner as Head of U.S. Commercial Operations 137

6.19 Jan 06, 2021: Abbott Hosts Conference Call for Fourth-Quarter Earnings 137

6.20 Oct 23, 2020: Mentice receives order of total SEK

7.1 million from ABBOTT 137

6.21 Aug 31, 2020: Onduo’s new prospective study published in the Journal of Medical Internet Research highlights the benefit of continuous glucose monitoring systems 138

6.22 Aug 06, 2020: Insulet to Announce Second Quarter 2020 Financial Results on August 6, 2020 139

6.23 Jul 30, 2020: Tandem Diabetes Care to Announce Second Quarter 2020 Financial Results on July 30, 2020 139

6.24 Jul 28, 2020: Nemaura signs letter of intent to acquire Healthimation 139

6.25 Jul 21, 2020: Henry Schein to Webcast Second Quarter 2020 Conference Call on Tuesday, August 4, 2020 at 10:00 A.M. ET 140

6.26 Jul 09, 2020: Edwards Lifesciences To Host Earnings Conference Call On July 23, 2020 140

6.27 Jun 09, 2020: Medtronic announces scientific data presentations at the American Diabetes Association 80th Scientific Sessions 140

7 Appendix 143

7.1 Methodology 143

7.2 About GlobalData 146

7.3 Contact Us 146

List of Tables

Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

Continuous Glucose Monitors – Pipeline Products by Territory 15

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

Continuous Glucose Monitors – Ongoing Clinical Trials 18

Continuous Glucose Monitors Companies – Pipeline Products by Stage of Development 19

Continuous Glucose Monitors – Pipeline Products by Stage of Development 22

Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview 25

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Status 25

FreeStyle Libre Flash Glucose Monitoring System – Children – Product Description 25

Abbott Diabetes Care Inc – Ongoing Clinical Trials Overview 26

FreeStyle Libre Flash Glucose Monitoring System – Children – Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial 27

Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview 28

My Medibit – Product Status 28

My Medibit – Product Description 28

Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview 29

Continuous Glucose Monitor – Product Status 29

Continuous Glucose Monitor – Product Description 29

Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30

GlucoPod CGM System – Product Status 30

GlucoPod CGM System – Product Description 30

Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 31

Blood Glucose Sensor – Product Status 31

Blood Glucose Sensor – Product Description 31

Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview 32

VSM 3 Glucose Monitoring System – Product Status 32

VSM 3 Glucose Monitoring System – Product Description 32

CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 33

Glucoband – Product Status 33

Glucoband – Product Description 33

CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview 34

Miniaturized Implantable Continuous Glucose Monitor – Product Status 34

Miniaturized Implantable Continuous Glucose Monitor – Product Description 34

City, University of London Pipeline Products & Ongoing Clinical Trials Overview 35

Non-Invasive Glucose Monitor – Product Status 35

Non-Invasive Glucose Monitor – Product Description 35

Columbia University Pipeline Products & Ongoing Clinical Trials Overview 36

Wearable Continuous Blood Glucose Monitoring Device – Product Status 36

Wearable Continuous Blood Glucose Monitoring Device – Product Description 36

ConvaTec Group Plc Pipeline Products & Ongoing Clinical Trials Overview 37

Closed Loop Continuous Glucose Monitoring System – Product Status 37

Closed Loop Continuous Glucose Monitoring System – Product Description 37

Cyber Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 38

Cybersensors Continuous Glucose Sensor – Product Status 38

Cybersensors Continuous Glucose Sensor – Product Description 38

DexCom Inc Pipeline Products & Ongoing Clinical Trials Overview 39

Dexcom G7 CGM System – Product Status 39

Dexcom G7 CGM System – Product Description 39

First-Gen Verily Sensor – Product Status 40

First-Gen Verily Sensor – Product Description 40

Echo Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 41

Gen 2 Symphony CGM System – Product Status 41

Gen 2 Symphony CGM System – Product Description 41

Symphony tCGM System – Home – Product Status 42

Symphony tCGM System – Home – Product Description 42

Symphony tCGM System – Hospital Critical Care – Product Status 42

Symphony tCGM System – Hospital Critical Care – Product Description 43

Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 44

Viscosimetric Glucose Sensor – Product Status 44

Viscosimetric Glucose Sensor – Product Description 44

eLutions Integrated Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview 45

Optically-Efficient Miniaturized Raman Optical System – Product Status 45

Optically-Efficient Miniaturized Raman Optical System – Product Description 45

EyeSense GmbH Pipeline Products & Ongoing Clinical Trials Overview 46

FiberSense System – Product Status 46

FiberSense System – Product Description 46

EyeSense GmbH – Ongoing Clinical Trials Overview 47

FiberSense System – Effectiveness and Safety Study of the Percutaneous Optical Fibre Glucose Sensor (FiberSense) for Home Use in Diabetic and Prediabetic Individuals 48

Flowsion A/S Pipeline Products & Ongoing Clinical Trials Overview 49

Glycostat – Product Status 49

Glycostat – Product Description 49

Gili Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 50

Diawatch – Product Status 50

Diawatch – Product Description 50

Globe Medical Tech Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 51

Continuous Glucose Monitoring Device – Product Status 51

Continuous Glucose Monitoring Device – Product Description 51

GlucoLight Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 52

SENTRIS-100 – Product Status 52

SENTRIS-100 – Product Description 52

Glucometrix AG Pipeline Products & Ongoing Clinical Trials Overview 53

Non-Invasive Blood Glucose Monitoring Device – Product Status 53

Non-Invasive Blood Glucose Monitoring Device – Product Description 53

Glucosense Diagnostics Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 54

Non-Invasive Blood Glucose Monitor – Product Status 54

Non-Invasive Blood Glucose Monitor – Product Description 54

GlucoSet AS Pipeline Products & Ongoing Clinical Trials Overview 55

GlucoSet Sensor – Product Status 55

GlucoSet Sensor – Product Description 55

GluMetrics Inc Pipeline Products & Ongoing Clinical Trials Overview 56

GluCath Intravascular Continuous Glucose Monitor – Product Status 56

GluCath Intravascular Continuous Glucose Monitor – Product Description 56

Glusense Ltd Pipeline Products & Ongoing Clinical Trials Overview 57

Glyde CGM – Product Status 57

Glyde CGM – Product Description 57

Glusense Ltd – Ongoing Clinical Trials Overview 58

Glyde CGM – A Study to Evaluate the Safety and Efficacy of the GluSense’s Glyde CGM Technology in Humans 59

GlySens Inc Pipeline Products & Ongoing Clinical Trials Overview 60

Eclipse ICGM System – Product Status 60

Eclipse ICGM System – Product Description 60

Second Generation ICGM System – Product Status 61

Second Generation ICGM System – Product Description 61

G-Sense Ltd. Pipeline Products & Ongoing Clinical Trials Overview 62

G-Sense Device – Product Status 62

G-Sense Device – Product Description 62

iGlyko, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63

iGlyko System – Product Status 63

iGlyko System – Product Description 63

Indigo Diabetes NV Pipeline Products & Ongoing Clinical Trials Overview 64

YANG Sensor – Product Status 64

YANG Sensor – Product Description 64

Indigo Diabetes NV – Ongoing Clinical Trials Overview 65

YANG Sensor – Early Feasibility and First in Human Study of the YANG System for Continuous Monitoring of Glucose, Ketones and Lactate – The GLOW Study 66

Innovosens AB Pipeline Products & Ongoing Clinical Trials Overview 67

Diabetic Sensor – Continuous Glucose Monitoring – Product Status 67

Diabetic Sensor – Continuous Glucose Monitoring – Product Description 67

Insulet Corp Pipeline Products & Ongoing Clinical Trials Overview 68

Omnipod Horizon Automated Glucose Control System – Product Status 68

Omnipod Horizon Automated Glucose Control System – Product Description 68

Integrated Medical Sensors Pipeline Products & Ongoing Clinical Trials Overview 69

Implantable Continuous Glucose Monitor – Product Status 69

Implantable Continuous Glucose Monitor – Product Description 69

Integrity Applications Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

GlucoTrack – DF-C – Product Status 70

GlucoTrack – DF-C – Product Description 70

GlucoTrack DF-F – Product Status 71

GlucoTrack DF-F – Product Description 71

GlucoTrack DF-F – Pre-diabetes – Product Status 71

GlucoTrack DF-F – Pre-diabetes – Product Description 72

Invivosense ASA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 73

IvSCGM Biosensor – Product Status 73

IvSCGM Biosensor – Product Description 73

I-Sens Inc Pipeline Products & Ongoing Clinical Trials Overview 74

Continuous Glucose Monitor – Product Status 74

Continuous Glucose Monitor – Product Description 74

iSense Corporation (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75

iSense CGM – Product Status 75

iSense CGM – Product Description 75

Keratin Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 76

Illume – Product Status 76

Illume – Product Description 76

Know Labs Inc Pipeline Products & Ongoing Clinical Trials Overview 77

UBAND – Product Status 77

UBAND – Product Description 77

KTH Royal Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 78

Microneedle Patch – Glucose Monitoring – Product Status 78

Microneedle Patch – Glucose Monitoring – Product Description 78

LEMM Technologies, LLC Pipeline Products & Ongoing Clinical Trials Overview 79

Non-Invasive Blood Glucose Monitor – Product Status 79

Non-Invasive Blood Glucose Monitor – Product Description 79

Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 80

Implantable Glucose Sensor – Product Status 80

Implantable Glucose Sensor – Product Description 80

Medical Wireless Sensing Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

GlucoWiSe – Product Status 81

GlucoWiSe – Product Description 81

Medtronic Diabetes Pipeline Products & Ongoing Clinical Trials Overview 82

Combo Set Glucose Monitoring System – Product Status 82

Combo Set Glucose Monitoring System – Product Description 82

Envision Pro Continuous Glucose Monitoring System – Product Status 83

Envision Pro Continuous Glucose Monitoring System – Product Description 83

Harmony 1 Sensor – Product Status 83

Harmony 1 Sensor – Product Description 83

Harmony 2 Sensor – Product Status 84

Harmony 2 Sensor – Product Description 84

iPro 3 Glucose Monitoring System – Product Status 84

iPro 3 Glucose Monitoring System – Product Description 84

ipro 4 Glucose Monitoring System – Product Status 85

ipro 4 Glucose Monitoring System – Product Description 85

ipro 5 Glucose Monitoring System Sensor – Product Status 85

ipro 5 Glucose Monitoring System Sensor – Product Description 86

Mellitor Ltd Pipeline Products & Ongoing Clinical Trials Overview 87

Mellitor Sensor – Product Status 87

Mellitor Sensor – Product Description 87

Metronom Health Inc Pipeline Products & Ongoing Clinical Trials Overview 88

CGM System – Product Status 88

CGM System – Product Description 88

mobiLIFE Pipeline Products & Ongoing Clinical Trials Overview 89

GlucoReader – Product Status 89

GlucoReader – Product Description 89

Nemaura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 90

sugarBEAT – Product Status 90

sugarBEAT – Product Description 91

Nemaura Medical Inc – Ongoing Clinical Trials Overview 92

sugarBEAT – Study is to Compare the sugarBEAT and Major Continuous Glucose Monitor Sensor in People with Diabetes 93

Newton Photonics Inc Pipeline Products & Ongoing Clinical Trials Overview 94

Non-invasive Blood Glucose Monitor – Product Status 94

Non-invasive Blood Glucose Monitor – Product Description 94

Northwestern University Pipeline Products & Ongoing Clinical Trials Overview 95

Continuous Glucose Sensor – Product Status 95

Continuous Glucose Sensor – Product Description 95

Orsus Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 96

Non-Invasive Blood Glucose Monitor – Product Status 96

Non-Invasive Blood Glucose Monitor – Product Description 96

PKvitality SAS Pipeline Products & Ongoing Clinical Trials Overview 97

K’Watch Glucose – Product Status 97

K’Watch Glucose – Product Description 97

PositiveID Corp Pipeline Products & Ongoing Clinical Trials Overview 98

Fully Synthetic Glucose Sensing System – Product Status 98

Fully Synthetic Glucose Sensing System – Product Description 98

Purdue University Pipeline Products & Ongoing Clinical Trials Overview 99

Soft Contact Lens – Glucose Monitoring – Product Status 99

Soft Contact Lens – Glucose Monitoring – Product Description 99

Senseonics Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 100

Eversense XL CGM System – Product Status 100

Eversense XL CGM System – Product Description 100

Senseonics Holdings Inc – Ongoing Clinical Trials Overview 101

Eversense XL CGM System – Evaluation of Long-term Implanted Sensor in Patients on Quality of Life 102

SensiVida Medical Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 103

Glucose Monitoring System – Product Status 103

Glucose Monitoring System – Product Description 103

Senzime AB Pipeline Products & Ongoing Clinical Trials Overview 104

CliniSenz – Product Status 104

CliniSenz – Product Description 104

Socrates Health Solutions, Inc. Pipeline Products & Ongoing Clinical Trials Overview 105

Companion CM – Product Status 105

Companion CM – Product Description 105

Stony Brook University Pipeline Products & Ongoing Clinical Trials Overview 106

GlucoREAD Patch – Product Status 106

GlucoREAD Patch – Product Description 106

Swansea University Pipeline Products & Ongoing Clinical Trials Overview 107

Flash Glucose Monitoring Device – Product Status 107

Flash Glucose Monitoring Device – Product Description 107

Hi-Tech Diabetes Blood Glucose Monitor – Product Status 108

Hi-Tech Diabetes Blood Glucose Monitor – Product Description 108

Tenax Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 109

Glucose Biosensor – Product Status 109

Glucose Biosensor – Product Description 109

Texas A&M University Pipeline Products & Ongoing Clinical Trials Overview 110

Minimally Invasive Glucose Monitoring System – Product Status 110

Minimally Invasive Glucose Monitoring System – Product Description 110

Ultradian Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 111

Biologue – Product Status 111

Biologue – Product Description 111

University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview 112

Dropsense Continuous Glucose Monitor – Product Status 112

Dropsense Continuous Glucose Monitor – Product Description 112

University of California Irvine Pipeline Products & Ongoing Clinical Trials Overview 113

Implantable Device – Diabetes Mellitus – Product Status 113

Implantable Device – Diabetes Mellitus – Product Description 113

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 114

Glucose Monitoring Tattoo – Product Status 114

Glucose Monitoring Tattoo – Product Description 114

University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview 115

Continuous Glucose Monitoring System – Product Status 115

Continuous Glucose Monitoring System – Product Description 115

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 116

Long Term Silicon Carbide (SiC) RF Antenna – Product Status 116

Long Term Silicon Carbide (SiC) RF Antenna – Product Description 116

University of Technology Sydney Pipeline Products & Ongoing Clinical Trials Overview 117

Hypo Detection System – Product Status 117

Hypo Detection System – Product Description 117

University of Texas at Arlington Pipeline Products & Ongoing Clinical Trials Overview 118

Nanotechnology Based Glucose Monitoring Device – Product Status 118

Nanotechnology Based Glucose Monitoring Device – Product Description 118

VeriTeQ Corporation Pipeline Products & Ongoing Clinical Trials Overview 119

GlucoChip – Product Status 119

GlucoChip – Product Description 119

Vytrace, Inc. Pipeline Products & Ongoing Clinical Trials Overview 120

Continuous Glucose Monitoring Device – Product Status 120

Continuous Glucose Monitoring Device – Product Description 120

WaveForm Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 121

Cascade Continuous Glucose Monitoring System – Product Status 121

Cascade Continuous Glucose Monitoring System – Product Description 121

WaveForm Technologies Inc – Ongoing Clinical Trials Overview 122

Cascade Continuous Glucose Monitoring System – Cascade CGM 15-Day US Performance Assessment 123

Zyvex Corp Pipeline Products & Ongoing Clinical Trials Overview 124

GeNI – Product Status 124

GeNI – Product Description 124

List of Figures

Continuous Glucose Monitors – Pipeline Products by Stage of Development 14

Continuous Glucose Monitors – Pipeline Products by Territory 15

Continuous Glucose Monitors – Pipeline Products by Regulatory Path 16

Continuous Glucose Monitors – Pipeline Products by Estimated Approval Date 17

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports